PMID- 9764357 OWN - NLM STAT- MEDLINE DCOM- 19981202 LR - 20190921 IS - 1046-7408 (Print) IS - 1046-7408 (Linking) VI - 40 IP - 3 DP - 1998 Sep TI - Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft. PG - 136-44 AB - PROBLEM: Human leukocyte antigen (HLA)-G is a major histocompatibility complex class I antigen, which is referred to as nonclassical because it displays a tissue-restricted distribution in the placenta, a reduced cytoplasmic domain, a limited polymorphism, and several isoforms. The HLA-G antigen is thought to play an essential role during pregnancy by protecting the semi-allogeneic fetus from recognition and destruction by maternal immune cells. METHOD OF STUDY: Alternative splicing of HLA-G mRNA was analyzed by Southern blot of reverse transcriptase-polymerase chain reaction products from trophoblasts of the first trimester of gestation and term placenta. The regulation of HLA-G gene expression was investigated by electrophoretic mobility shift assays using nuclear extracts from cells expressing different levels of HLA-G gene activity. Using polymerase chain reaction-single strand conformational polymorphism and sequencing, we studied HLA-G gene polymorphism in families from the Centre d'Etude du Polymorphisme Humain in Paris. To understand the function of the HLA-G molecule, cytotoxicity assays were carried out with peripheral blood mononuclear cells or polyclonal natural killer effectors cells from 30 different donors against HLA-G1 and HLA-G2 transfectants. RESULTS: Four main aspects have been elucidated: 1) The primary transcript of the HLA-G gene is alternatively spliced into five main mRNA forms: HLA-G1 (full length), HLA-G2 (minus exon 3), which encodes a membrane-bound isoform associated with beta-2 microglobulin, HLA-G3 (minus exons 3 and 4), HLA-G4 (minus exon 4), and HLA-G5 (plus intron 4), which encodes a soluble form of the HLA-G antigen; 2) specific nuclear factors bind to an important regulatory element located more than 1.2 kb from the HLA-G gene. Three specific complexes are observed in cells that show HLA-G transcriptional activity and an additional factor that could correlate with the repression of HLA-G gene expression that is detected in natural killer cells; 3) we observed an important genomic polymorphism in exon 3 but a very low polymorphism at the protein level; 4) HLA-G1 and HLA-G2 transfectants clearly demonstrated that both HLA-G isoforms are capable of inhibiting natural killer lytic activity. CONCLUSION: These results suggest that HLA-G acts as the public ligand for natural killer inhibitory receptors, thus protecting the fetus against maternal rejection. FAU - Moreau, P AU - Moreau P AD - Departement de Recherche Medicale, Hopital Saint-Louis, Paris, France. FAU - Paul, P AU - Paul P FAU - Rouas-Freiss, N AU - Rouas-Freiss N FAU - Kirszenbaum, M AU - Kirszenbaum M FAU - Dausset, J AU - Dausset J FAU - Carosella, E D AU - Carosella ED LA - eng PT - Journal Article PL - Denmark TA - Am J Reprod Immunol JT - American journal of reproductive immunology (New York, N.Y. : 1989) JID - 8912860 RN - 0 (HLA Antigens) RN - 0 (HLA-G Antigens) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Protein Isoforms) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Immunologic) SB - IM MH - Alternative Splicing MH - Cytotoxicity, Immunologic MH - Female MH - Fetal Tissue Transplantation/immunology MH - HLA Antigens/biosynthesis/*genetics/*immunology MH - HLA-G Antigens MH - Histocompatibility Antigens Class I/biosynthesis/*genetics/*immunology MH - Humans MH - Immune Tolerance/immunology MH - Killer Cells, Natural/immunology MH - Maternal-Fetal Exchange/immunology MH - Polymorphism, Genetic MH - Pregnancy MH - Protein Isoforms/biosynthesis/genetics/immunology MH - RNA, Messenger/metabolism MH - Receptors, Immunologic/immunology/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transfection MH - Transplantation, Homologous MH - Trophoblasts/metabolism EDAT- 1998/10/09 00:00 MHDA- 1998/10/09 00:01 CRDT- 1998/10/09 00:00 PHST- 1998/10/09 00:00 [pubmed] PHST- 1998/10/09 00:01 [medline] PHST- 1998/10/09 00:00 [entrez] AID - 10.1111/j.1600-0897.1998.tb00405.x [doi] PST - ppublish SO - Am J Reprod Immunol. 1998 Sep;40(3):136-44. doi: 10.1111/j.1600-0897.1998.tb00405.x.